CAPITOL HEALTH LIMITED (CAJ)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
![](/stocklogo/CAJ.jpg)
CAJ - CAPITOL HEALTH LIMITED
FNArena Sector :
Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.36
Index: ALL-ORDS
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.36
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.305
25 Jul |
0.000 OPEN $0.31 |
0.000 HIGH $0.31 |
2,105,985 LOW $0.30 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ACL . AHX . ALC . BMT . DOC . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 1.1 | 35.0 | xxx |
DPS (cps) | xxx | 1.0 | 1.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | 0.0% | 0.0% | xxx |
PE Ratio | xxx | N/A | 0.8 | xxx |
Dividend Yield | xxx | N/A | 3.4% | xxx |
Div Pay Ratio(%) | xxx | N/A | 2.9% | xxx |
Last ex-div: 06/03 - ex-div 0.5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -1.1 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 209.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 12.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 37.5 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -5.44 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -7.85 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -4.70 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -3.87 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -7.85 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 6.08 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 10.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 12 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 123 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 135 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 157 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 19 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.09 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 16.8 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 8.04 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 172 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 22 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 2 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
![](/images/chart-unavailable.png)
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
CAJ STOCK CHART
![](/wp-content/uploads/2020/10/img-side-banner-stock-analysis.jpg)
FNArena News on CAJ
1 |
In Brief: Airlines, Pathology & SeekJul 12 2024 - Weekly Reports |
2 |
Weekly Ratings, Targets, Forecast Changes – 28-06-24Jul 01 2024 - Weekly Reports |
3 |
Building The No 3 Diagnostic Imaging PlayerJun 19 2024 - Small Caps |
4 |
Australian Broker Call *Extra* Edition – Jun 19, 2024Jun 19 2024 - Daily Market Reports |
5 |
ESG Focus: The Little Big Things – 15-05-2024May 15 2024 - ESG Focus |
Latest Healthcare services News
1 |
Building The No 3 Diagnostic Imaging PlayerJun 19 2024 - Small Caps |
2 |
Capitol Health’s Higher Margin OutlookMar 13 2024 - Small Caps |
3 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
4 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
5 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
6 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
7 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
8 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
9 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
10 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |